Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

411 results about "Cochlear implantation" patented technology

A cochlear implant ( CI) is a surgically implanted neuroprosthetic device that provides a sense of sound to a person with moderate to profound sensorineural hearing loss. Cochlear implants bypass the normal acoustic hearing process, instead replacing it with electric signals which directly stimulate the auditory nerve.

Electronic translator for assisting communications

An electronic translator translates input speech into multiple streams of data that are simultaneously delivered to the user, such as a hearing impaired individual. Preferably, the data is delivered in audible, visual and text formats. These multiple data streams are delivered to the hearing-impaired individual in a synchronized fashion, thereby creating a cognitive response. Preferably, the system of the present invention converts the input speech to a text format, and then translates the text to any of three other forms, including sign language, animation and computer generated speech. The sign language and animation translations are preferably implemented by using the medium of digital movies in which videos of a person signing words, phrase and finger spelled words, and of animations corresponding to the words, are selectively accessed from databases and displayed. Additionally the received speech is converted to computer-generated speech for input to various hearing enhancement devices used by the deaf or hearing-impaired, such as cochlear implants and hearing aids, or other output devices such as speakers, etc. The data streams are synchronized utilizing a high-speed personal computer to facilitate sufficiently fast processing that the text, video signing and audible streams can be generated simultaneously in real time. Once synchronized the data streams are presented to the subject concurrently in a method that allows the process of mental comprehension to occur. The electronic translator can also be interfaced to other communications devices, such as telephones. Preferably, the hearing-impaired person is also able to use the system's keyboard or mouse to converse or respond.
Owner:INTERACTIVE SOLUTIONS

Focused stimulation in a medical stimulation device

ActiveUS20060247735A1Narrowing of the stimulation regions minimizes or prevents this from occurringHead electrodesDeaf-aid setsCochlear implantationImplant electrode
A medical stimulation device such as a cochlear implant configured to provide stimulation of one or more spatially-restricted contiguous portion(s) of the spiral array of auditory nerve fibers in the cochlear (“discrete stimulation regions”). Each discrete stimulation region is defined by the constructive and / or destructive interference of stimulating and limiting signals simultaneously applied to electrode channels of an implanted electrode array, the stimulating and limiting signals being determined based upon transimpedance measurements of intracochlear electrode channels of the implanted electrode array representing specific spread functions of an individual recipient. The stimulating signal is preferably applied through a targeted electrode channel; that is, one or more successive electrodes which is / are adjacent to the discrete stimulation region. The targeted electrode channel is selected to represent a sound based on the outputs of a sound processor to stimulate neural activity in the discrete stimulation region to thereby cause a percept of the represented sound. The size of the discrete stimulation region is defined by the limiting signal(s) applied to electrode channel(s) other than the targeted electrode channel, and which negate(s) current spread which would otherwise occur in response to the stimulating signal.
Owner:COCHLEAR LIMITED

Method and system for generating a cochlear implant program using multi-electrode stimulation to elicit the electrically-evoked compound action potential

A multichannel cochlear implant system spatially spreads the excitation pattern in the target neural tissue by either: (1) rapid sequential stimulation of a small group of electrodes, or (2) simultaneously stimulating a small group of electrodes. Such multi-electrode stimulation stimulates a greater number of neurons in a synchronous manner, thereby increasing the amplitude of the extra-cellular voltage fluctuation and facilitating its recording. The electrical stimuli are applied simultaneously (or sequentially at a rapid rate) on selected small groups of electrodes while monitoring the evoked compound action potential (ECAP) on a nearby electrode. The presence of an observable ECAP not only validates operation of the implant device at a time when the patient may be unconscious or otherwise unable to provide subjective feedback, but also provides a way for the magnitude of the observed ECAP to be recorded as a function of the amplitude of the applied stimulus. From this data, a safe, efficacious and comfortable threshold level can be obtained which may be used thereafter as the initial setting of the stimulation parameters of the neurostimulation device, or to guide the setting of the stimulation parameters of the neurostimulation device.
Owner:ADVNACED BIONICS LLC

System for generating a cochlear implant program using multi-electrode stimulation to elicit the electrically-evoked compound action potential

A multichannel cochlear implant system spatially spreads the excitation pattern in the target neural tissue by either: (1) rapid sequential stimulation of a small group of electrodes, or (2) simultaneously stimulating a small group of electrodes. Such multi-electrode stimulation stimulates a greater number of neurons in a synchronous manner, thereby increasing the amplitude of the extra-cellular voltage fluctuation and facilitating its recording. The electrical stimuli are applied simultaneously (or sequentially at a rapid rate) on selected small groups of electrodes while monitoring the evoked compound action potential (ECAP) on a nearby electrode. The presence of an observable ECAP not only validates operation of the implant device at a time when the patient may be unconscious or otherwise unable to provide subjective feedback, but also provides a way for the magnitude of the observed ECAP to be recorded as a function of the amplitude of the applied stimulus. From this data, a safe, efficacious and comfortable threshold level can be obtained which may be used thereafter as the initial setting of the stimulation parameters of the neurostimulation device, or to guide the setting of the stimulation parameters of the neurostimulation device.
Owner:ADVNACED BIONICS LLC

Dual microphone EAS system that prevents feedback

A hearing prosthesis includes both a hearing aid adapted to sense and amplify low frequency acoustic sound signals and a cochlear implant system adapted to sense high frequency acoustic sound signals. The hearing aid has a first microphone adapted to sense the low frequency acoustic sound signals, amplify these sensed low frequency acoustic sound signals, and present the resulting amplified low frequency acoustic sound signals in the ear canal of a user, thereby enabling the user to better hear these amplified sounds using his or her normal hearing processes. The cochlear implant system includes a second microphone adapted to sense the high frequency acoustic sound signals and selectively stimulate the inner ear with electrical stimulation that will be perceived as high frequency acoustic sound signals. Both the cochlear implant system and the hearing aid system are coupled to operate on the same ear of the user. Feedback within the hearing aid portion of the system is eliminated by positioning the first microphone at a location that is acoustically remote from the ear canal where the amplified low frequency acoustic sound signals are presented. High frequency acoustic sound signals are better sensed by placing the second microphone at a location that is in or near the ear canal where the amplified low frequency acoustic sound signals are presented.
Owner:ADVANCED BIONICS AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products